troglitazone has been researched along with angiotensin ii in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Graf, K; Hsueh, WA; Law, RE; Xi, XP | 1 |
| Fleck, E; Goetze, S; Graf, K; Hsueh, WA; Law, RE; Xi, XP | 1 |
| Funakoshi, Y; Hirano, K; Ichiki, T; Iino, N; Kanaide, H; Takeda, K; Takeshita, A; Tokunou, T | 1 |
| Ikeda, U; Lee, RT; Ohki, R; Shimada, K; Yamamoto, K | 1 |
| Abe, M; Arima, S; Ikeda, Y; Ito, S; Kohagura, K; Omata, K; Sugawara, A; Takeuchi, K; Taniyama, Y | 1 |
| Asakawa, M; Hasegawa, H; Kadowaki, T; Komuro, I; Kubota, N; Masuda, Y; Nagai, T; Saito, T; Takano, H; Uozumi, H | 1 |
| Chikara, S; Fukuda, N; Hu, WY; Kanmatsuse, K; Kishioka, H; Nakayama, M; Teng, J | 1 |
| Hayashi, K; Homma, K; Kanda, T; Saruta, T; Takamatsu, I; Tatematsu, S; Wakino, S; Yoshioka, K | 1 |
| Blum, WF; Hauner, H; Skurk, T; van Harmelen, V | 1 |
| Li, YQ; Niu, XL; Wang, CX; Wang, SJ; Wei, J; Zhou, J | 1 |
| Bai, YT; Jia, G; Min, Q; Wu, J; Xiang, JZ | 1 |
12 other study(ies) available for troglitazone and angiotensin ii
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Calcium-Calmodulin-Dependent Protein Kinases; Cell Movement; Cells, Cultured; Chromans; DNA; Enzyme Activation; Hypoglycemic Agents; Muscle, Smooth, Vascular; Rats; Thiazoles; Thiazolidinediones; Troglitazone; Vasoconstrictor Agents | 1997 |
Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Calcium-Calmodulin-Dependent Protein Kinases; Cell Nucleus; Cells, Cultured; Chromans; Cytoplasm; Kinetics; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Protein Kinase C; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazoles; Thiazolidinediones; Troglitazone; Vasodilator Agents | 1999 |
Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Chromans; Down-Regulation; Gene Expression Regulation; Muscle, Smooth, Vascular; Promoter Regions, Genetic; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Receptors, Cytoplasmic and Nuclear; RNA Stability; RNA, Messenger; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2000 |
Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Biological Transport; Cardiomegaly; Cells, Cultured; Chromans; Heart; Leucine; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Phenylephrine; Prostaglandin D2; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Stress, Mechanical; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |
Biphasic vasodilator action of troglitazone on the renal microcirculation.
Topics: Angiotensin II; Animals; Arterioles; Calcium Channel Blockers; Chromans; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; In Vitro Techniques; Male; Microcirculation; Rabbits; Renal Circulation; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2002 |
Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cell Size; Cells, Cultured; Chromans; Disease Models, Animal; Gene Expression; Heart; Heterozygote; Hypoglycemic Agents; Ligands; Mice; Mice, Knockout; Myocardium; Organ Size; Pioglitazone; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cell Division; Cells, Cultured; Chromans; Depression, Chemical; DNA; Growth Substances; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Thiazoles; Thiazolidinediones; Troglitazone; Tyrosine | 2002 |
Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
Topics: Angiotensin II; Animals; Blood Pressure; Cell Cycle Proteins; Cells, Cultured; Chromans; Hypertension; Intracellular Signaling Peptides and Proteins; Ligands; Male; Muscle, Smooth, Vascular; Pioglitazone; Platelet-Derived Growth Factor; PPAR gamma; Protein Phosphatase 2; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-vav; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction; Thiazolidinediones; Troglitazone | 2004 |
Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway.
Topics: Adipocytes; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Butadienes; Cells, Cultured; Chromans; Drug Interactions; Extracellular Signal-Regulated MAP Kinases; Female; Fibrinolytic Agents; Humans; Leptin; MAP Kinase Signaling System; Nitriles; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thiazolidinediones; Troglitazone | 2005 |
[Peroxisome proliferator-activated receptor activator troglitazone inhibits angiotensin II-stimulated secretion of vasoactive factors by endothelial cells].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cell Line; Chromans; Dose-Response Relationship, Drug; Endothelial Cells; Endothelin-1; Gene Expression Regulation; Humans; Hypertension; Immunohistochemistry; Losartan; Nitric Oxide; PPAR gamma; Receptor, Angiotensin, Type 1; Thiazolidinediones; Troglitazone | 2007 |
High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells.
Topics: Angiotensin II; Cell Adhesion Molecules; Cells, Cultured; Chromans; Coronary Vessels; Dose-Response Relationship, Drug; Endothelium, Vascular; Gene Silencing; Glucose; Humans; PPAR gamma; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Thiazolidinediones; Troglitazone; Up-Regulation | 2010 |